Clinical Trial Update: Regenerative Combined Therapy With Enamel Matrix Derivative and Biphasic Calcium Phosphate Graft [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating enamel matrix derivative with biphasic calcium phosphate graft for intrabony periodontal defects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Disease

Drugs mentioned

• Biphasic Calcium Phosphate Graft (Biphasic calcium phosphate bone graft)
• Emdogain (Enamel Matrix Derivative)

Snippet

Sponsor: Universitat Internacional de Catalunya | Conditions: Intrabony Periodontal Defect | Phase 4 | Status: COMPLETED